Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tereos Starch & Sweeteners, formerly known as Syral, is a major European producer of starch and starch derivatives, including a specialized range of pharmaceutical-grade excipients. The company provides essential ingredients such as glucose, maltodextrin, and sorbitol used in the formulation of oral dosage forms, syrups, and injectable solutions. As a subsidiary of the Tereos Group, it operates multiple production facilities across Europe and China, serving the pharmaceutical, nutraceutical, and food industries. Their healthcare portfolio focuses on high-purity carbohydrates that meet international pharmacopoeia standards for drug stability and delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S. Syral.